SEEL

Seelos Therapeutics, Inc. Common Stock
SEEL

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

SEEL was delisted on the 15th of October, 2024.

Back to rankings

14 hedge funds and large institutions have $145K invested in Seelos Therapeutics, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
14
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$46.9K
2
+$35.6K
3
+$31.8K
4
Bank of America
Bank of America
North Carolina
+$8

Top Sellers

1
-$32.1K
2
-$7.64K
3
-$2.69K
4
TRCT
Tower Research Capital (TRC)
New York
-$549
5
BlackRock
BlackRock
New York
-$308
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$68K
2
$40.6K
3
$31.8K
4
$2.54K
5
$1.33K
6
$357
7
$233
8
$120
9
$116
10
$45
11
$27
12
$26
13
$8
14
$4
15
–
16
–
17
–
18
–
19
–
20
–
21
–
22
–
23
–